Why is ERIS Lifescience falling/rising?

As of 20-Jun, ERIS Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 1,624.10, which reflects a decrease of Rs 104.65 or 6.05%. The stock has underperformed its sector by 6.66% today and has been on a consecutive downward trend for the last four days, resulting in a total decline of 12.5% during this period. Despite a strong performance over the past year with a return of 57.40%, the stock's recent volatility, with an intraday low of Rs 1,575.1 and high volatility of 7.13%, indicates significant market fluctuations. Additionally, the delivery volume has dropped by 78.36% against the 5-day average, suggesting falling investor participation, which may contribute to the stock's downward movement.
In the broader market context, the stock's short-term performance has been notably weaker than the benchmark, with a 1-week return of -8.94% compared to the Sensex's gain of 1.59%. While ERIS Lifesciences has shown strong long-term growth and management efficiency, concerns about its high valuation and a decline in profits over the past year may be weighing on investor sentiment. The company's low Debt to EBITDA ratio and high institutional holdings indicate some positive fundamentals; however, the recent poor performance and high volatility could be overshadowing these strengths, leading to the current decline in stock price.